Vicasol, tablets 15 mg 30 pcs

Liver cirrhosis, Bleeding, Menstrual disorders, Hepatitis

• bleeding after wounds or surgery;
• bleeding gastrointestinal;
• hemorrhoidal and prolonged nasal bleeding;
• uterine bleeding;
• pulmonary bleeding against tuberculosis.

.

Indications

bleeding after wounds or surgery;
gastrointestinal bleeding;
hemorrhoidal and prolonged nosebleeds;
uterine bleeding;
pulmonary hemorrhages due to tuberculosis.

Pharmacological effect

Antihemorrhagic agent.

Special instructions

For diseases leading to impaired bile outflow, parenteral administration is recommended. For hemophilia and Werlhof’s disease, the drug is ineffective.

Weakens the effects of indirect anticoagulants.

For the prevention of hemorrhagic disease of newborns, phytonadione is more preferable than menadione sodium bisulfite, since it is less likely to cause hyperbilirubinemia and hemolytic anemia in newborns (including premature infants).

Impact on the ability to drive vehicles and operate machinery

During treatment with the drug, you should refrain from driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Active ingredient

Menadione sodium bisulfite

Composition

1 tablet contains 15 mg of menadione sodium bisulfite.

Contraindications

hypersensitivity to the components of the drug;
increased blood clotting, thromboembolism;
hemolytic disease of the newborn.

With caution: 6-phosphate dehydrogenase deficiency, liver failure.

Side Effects

Allergic reactions: facial flushing, skin itching, skin rash, bronchospasm.
From the blood system: hemolytic anemia, hemolysis in newborns with congenital deficiency of glucose-6-phosphate dehydrogenase, hemolytic disease of the newborn.
Local reactions: pain and swelling at the injection site, skin lesions in the form of spots with repeated injections into the same place.
Other: hyperbilirubinemia, jaundice (including kernicterus in infants), dizziness, transient decrease in blood pressure, profuse sweat, tachycardia, weak pulse filling, changes in taste sensations.

Interaction

Antacids reduce absorption due to the precipitation of bile salts in the initial part of the small intestine.

Does not affect the anticoagulant activity of heparin.

Simultaneous administration with broad-spectrum antibiotics, quinidine, quinine, salicylates in high doses, antibacterial sulfonamides requires an increase in the dose of vitamin K.

Cholestyramine, colestipol, mineral oils, sucralfate, dactinomycin reduce the absorption of vitamin K, which requires increasing its dose.

Concomitant administration with hemolytic drugs increases the risk of side effects

Overdose

Rarely – hypervitaminosis K, manifested by hyperprothrombin and hyperthrombinemia, hyperbilirubinemia, increased blood clotting, thromboembolism. Treatment is symptomatic.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 ° C.

Shelf life

2 years

Manufacturer

Biosynthesis, Russia